Remedy has announced that Jean-Charles Gaudechon will be its new CEO, effective March 1st. He will take over the position from interim CEO and co-founder Markus Mäki.
The announcement comes a day before the scheduled release of their 2015 Annual Report, which will be sent to investors tomorrow morning, with a webcast set to follow. The search for a new CEO began in October, after Tero Virtala stepped down from the role.
“I am delighted to announce the appointment of Jean-Charles (JC) Gaudechon to lead Remedy into a phase of profitable growth," states Henri Österlund, Chairman of the Board of Directors. "His proven history in growing gaming franchises and successfully leading international studios is an excellent fit to the current stage of Remedy’s business. Under JC’s leadership, we are well-positioned to significantly accelerate growth, guide Remedy towards greater independence through self-publishing, and deliver sustained value to our players, partners, and shareholders."
Gaudechon has twenty years of experience in the game industry, having started as a Producer at EA back in mid-2002. He has been working at Electronic Arts for 15 years, first in Sweden and later in Singapore. With a stint as General Manager & Executive Producer at CCP Games. While in recent years, he's explored new industries, he's making a return to games as Remedy's CEO.
In today's press release, Jean-Charles Gaudechon writes, "I’m excited and honored to join Remedy at a pivotal time. The studio has a unique creative identity and a strong pipeline. My commitment is to protect what makes it special, deliver exceptional games, and scale Remedy in a way that builds lasting value. Remedy has the voice and the ambition to be a pillar of the industry’s future. We will stay close to players, earn their time and trust, and strengthen our independence in how we build and publish our games, while continuing to work closely with the partners who have supported us along the way. I will be moving to Finland with my family and I’m incredibly excited about getting to work directly with the team at the studio."
Source: Remedy's Investor Press Release
